CHL Medical Partners
50
27M
29
1.47
7
0.42
15
- Stages of investment
- Areas of investment
Summary
CHL Medical Partners is the famous VC, which was founded in 1990. The main office of represented VC is situated in the Stamford. The company was established in North America in United States.
The fund is generally included in 2-6 deals every year. The average startup value when the investment from CHL Medical Partners is 10-50 millions dollars. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this CHL Medical Partners performs on 4 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2015. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the CHL Medical Partners, startups are often financed by Insight Partners, Venrock, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are Canaan Partners, Insight Partners, Venrock. In the next rounds fund is usually obtained by Canaan Partners, New Enterprise Associates, Insight Partners.
Among the various public portfolio startups of the fund, we may underline PrimeraDx (Primera Biosystems), POINT Biomedical, Vertos Medical The fund has exact preference in some founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Hospital. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 50
- Lead investments
- 7
- Exits
- 15
- Rounds per year
- 1.47
- Follow on index
- 0.42
- Investments by industry
- Biotechnology (38)
- Health Care (35)
- Medical (19)
- Therapeutics (14)
- Pharmaceutical (11) Show 17 more
- Investments by region
-
- United States (48)
- Peak activity year
- 2007
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 18M
- Group Appearance index
- 0.92
- Avg. company exit year
- 8
- Avg. multiplicator
- 0.03
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Amicus Therapeutics | 08 Sep 2005 | Biotechnology, Health Care, Pharmaceutical, Therapeutics | Late Stage Venture | 55M | United States, New Jersey |
| Resolvyx Pharmaceuticals | 22 Apr 2008 | Biotechnology, Pharmaceutical, Therapeutics | Early Stage Venture | 25M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.